跳至主要内容
临床试验/NCT00442819
NCT00442819已完成4 期

Uremic Pruritus, Cytokines and Polymethylmethacrylate Artificial Kidney

China Medical University Hospital2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2006年7月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
30
试验地点
2
主要终点
Improvement of uremic pruritus

研究概览

简要总结

Background: Uremic pruritus is one of the common complications in long-term dialysis patients. In general, many factors including xerosis, elevated serum calcium, phosphate, calcium-phosphate product, hyperparathyroidism and inadequate dialysis may contribute to it. Recently, researchers reported that immuno-hypothesis with high serum level of cytokines could be the cause of uremic pruritus. Polymethylmethacrylate (PMMA) artificial kidney (AK) has been reported to adsorb more serum cytokines than other high flux artificial kidneys.

Methods: In July 2006, 30 patients with severe uremic pruritus from 300 chronic hemodialysis patients in a single center entered this prospective study. Their dialyzers were changed to PMMA AK for 4 weeks. The severity of pruritus was evaluated every week using the results of a questionnaire (pruritus score). Laboratory assays including pre-dialysis serum blood urea nitrogen, creatinine, β2-microgblubulin (β2M), calcium, phosphate, intact parathyroid hormone (iPTH), total CO2, ferritin, hematocrit, high sensitivity C-reactive protein (hsCRP), IL-1, IL-2, IL-6, IL-18, TNF-α, KT/V and β2M clearance were measured before and at the end of 4 weeks of PMMA AK use.

Expected Results:To prove the PMMA membrane could improve the uremic pruritus and to reveal the effect of PMMA membrane on serum level of possible factors contributing to uremic pruritus.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
26 Years 至 82 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with chronic pruritus (>3 months) were screened using traditional visual analogue scale (VAS) and then scored using a pruritus questionnaire (pruritus scoring system).
  • Other inclusion criteria were that patients enrolled should be dialysed for 4 hours, three times a week, with KT/V >1.2, serum albumin> 3.0 mg/dl, hematocrit > 24%, ferritin < 900 ng/ml, phosphate <7 mg/dl, corrected calcium <11 mg/dl, calcium-phosphate product < 70, intact parathyroid hormone (iPTH) <600 pg/ml, and normal serum level of alanine aminotransferase and bilirubin in past 3 months.

排除标准

  • Pruritus unrelated to renal failure
  • Evidence of malignancy
  • Liver cirrhosis diagnosed by echogram or admission within 3 months of the start of the study.

结局指标

主要结局

Improvement of uremic pruritus

次要结局

  • Change of serum level of cytokines

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验